Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33863710

about

EGFR Signaling in Liver Diseases Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials Molecular prognostic prediction in liver cirrhosis Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?Combination treatment including targeted therapy for advanced hepatocellular carcinoma Clinical Advancements in the Targeted Therapies against Liver Fibrosis.T2 relaxation time is related to liver fibrosis severity.Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells.Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Kenneth tanabe works to solve the mysteries of liver cancer: while progress has been relatively slow, this noted expert sees reasons for hope.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling Hepatitis C virus-induced hepatocellular carcinoma Cancer biomarker discovery and validation.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro In vitro reversion of activated primary human hepatic stellate cells Long-term influence of sialoadenectomy on the liver of male albino rat.Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis SYSTEM-WIDE MAPPING OF ACTIVATED CIRCUITRY IN EXPERIMENTAL SYSTEMIC INFLAMMATORY RESPONSE SYNDROME.Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction.Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells.The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC.miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway.Effect of Exogenous Fetuin-A on TGF-β/Smad Signaling in Hepatic Stellate Cells.

P2860

Q26771265-3B4E7341-C6BD-4FD4-8311-B9DCB8ACCA6B Q26771518-F3698779-8C1D-42FA-9757-6ADE506BB0B3 Q26772800-979897C0-0A81-4F59-8283-F09985B5AD99 Q26784251-943270CD-C44E-4905-B42F-878EC6E69CA9 Q28068710-3110D6B2-6CCD-460C-AD31-BA187400B139 Q28077738-C00AB7C1-40E5-492A-A164-7F05EEAE712F Q28078684-44BADFA4-A2DB-4995-A46B-4E0FD0C76402 Q30383680-948505F0-23D9-4A07-B15A-604AA3C5D2CE Q33605760-E966F997-7F85-4690-81E0-6D5C39E54B15 Q33731782-A12550D2-EE3B-413C-81E1-7C2EB6C96A9C Q34482519-4A801F48-DC56-4F21-9E04-D8CE14AA61B6 Q34747195-81BB97BD-5DC4-45A1-89E9-55F07E98F35F Q34973496-5837ABBA-D553-486E-9B37-7DA55F00662B Q35107005-9A26B98E-8060-497F-8720-66D804DF4F6A Q35147435-69D79AAE-ED9F-4F33-A5DD-A32186AA3D4E Q35170154-43A7DD0A-DF9A-495D-9CB8-CDFF543840BB Q35229774-FAADB3BF-F5F2-47DD-AF15-607F115B6765 Q35619104-4928FA27-7B6E-4274-9142-4D5F9B26D9E5 Q35639692-9AC39198-445C-43AA-8D4A-FF5736F76308 Q35652772-EA709A9E-2138-42AA-B67F-B99E2F3B364D Q35742375-DB5BA2FC-DCA6-4C47-9321-18578EA41DB1 Q35824057-F49DEC7C-F05A-4003-AB2E-E8A7A12C0A7A Q35879887-4E85DA87-5CBE-4099-A0C3-A500B54FACA2 Q35881575-5D646C03-80D3-4662-9B5C-41D0091BD808 Q35903156-7E02C936-D63D-45A7-9039-2033F2EC0FA4 Q35923294-D3C481B5-BBC2-414C-A7C6-92A76677AC3C Q36372374-DD6CB626-24C5-4FCE-9CFF-BEF1DFCA609C Q36382083-3D23BF16-5338-4CD0-8ECD-2C8EAE4E0510 Q36470840-75A7ECFF-A645-40A1-B951-6403752C9F58 Q36471673-E6056885-26F8-4342-BB3D-14B201202933 Q36616276-C26830E6-FF04-4885-8537-0E3DD8762A66 Q36788544-091E38A0-24C4-4DE6-9FC8-47F985629D4C Q36879598-DC2E81E0-C2E9-465D-A1BB-CA75A130C2C3 Q36918035-EA1E922A-5682-433F-9373-CC406CD635A2 Q37526953-E61BF925-4541-4348-B7E5-AEB67D1125BE Q37678954-6E8B6F41-96B4-4A6E-98C9-917E19906046 Q38602815-7DA7E664-8BB2-4681-AD8E-51C735DCF838 Q38610677-628295D1-463F-480F-91DD-B16F7AF1A4E5 Q38687165-71B0AD0F-DAC3-4FCD-85E0-E5A83E4F0697 Q38725540-BC9A1C25-C32E-45EA-901C-33B2D3099320

P2860

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33863710

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@ast

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@en

type

label

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@ast

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@en

prefLabel

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@ast

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@en

P1433

Q33863710-46A87AC3-8597-4DB4-9916-65508BEEB5D0

P1476

Q33863710-DBF76F33-4C03-42EE-8D0C-4C9417F2B997

P2093

Q33863710-0207ADF9-F8D8-4745-A342-289EF726FB8C

Q33863710-17D6E7E1-F3A9-481B-86B3-665136BA8E77

Q33863710-2040BE2D-8279-4587-ADB1-DE06E234A9C8

Q33863710-205EBF6E-1DCC-4BE4-908F-F3890A65888B

Q33863710-299DCD3E-D6C9-405E-9243-42EBBA823238

Q33863710-3B809B73-D4F1-40FD-879E-D8AB9C00F1EB

Q33863710-4B05E623-362E-4547-ACD5-359600DFBAAF

Q33863710-4B5A8E4D-28F0-4C4F-83FB-48EB4E8F7D79

Q33863710-4D34876D-1CCE-4A75-B561-4832122F4D3E

Q33863710-61179DCC-CAA2-4B4B-900B-378C349CA423

P2860

Q33863710-0EBA6F4E-6FEB-42AD-AF0B-C5DED401847C

Q33863710-22A33E13-519D-49E2-921C-B12F950CB842

Q33863710-32F50A63-F3A2-4829-BD5D-AD2DF022F46B

Q33863710-377D2949-2A53-430A-BB28-CB3942C98BCF

Q33863710-4B3F5F24-8B0D-4A20-8005-A515D47AE859

Q33863710-4EAB9A01-72C2-4B48-A663-CB827B8F0490

Q33863710-605A8D5A-B894-4BA7-898A-6A2327288C91

Q33863710-61EA9BA7-95AB-4C36-99C1-2B3ED107E517

Q33863710-64F2708F-6744-459F-A8D2-AAC7FBC0C3D1

Q33863710-6C99F46E-10E2-44F2-A948-824C7357843C

P304

Q33863710-A45A01F3-6780-4E9A-B2F6-FBB2E5F3C87B

P31

Q33863710-6027A4BC-DC8B-493C-95FB-7B111A572A48

P356

Q33863710-E63B9F14-FBEB-4FA0-A147-CF0B301531E1

P407

Q33863710-8F861756-D4A6-4738-9282-1FD3DC1D1FE4

P433

Q33863710-3E37AF85-8828-43AD-A91F-1366937349DD

P478

Q33863710-2E5DBAF7-BE3A-4ACF-AFBE-E2851F95415D

P50

Q33863710-25B9BAB4-B383-4210-A2EF-00739DB8C975

Q33863710-79E847E3-F839-4845-96C2-C484F8382478

Q33863710-AA9A2602-2A4C-4FEB-9D1C-9033ABEDCE12

Q33863710-C70DAE3A-7C24-4939-BBD0-8CA2ECABD408

P577

Q33863710-6EEB2EA2-8851-4446-9F02-46C025E143A6

P5875

Q33863710-0FD8B105-9890-45A1-802E-12694379C7CA

P698

Q33863710-5A614945-B79A-4D15-B489-79532BF13000

P932

Q33863710-BA046EEE-5A31-4C2C-BE83-1F560C6C99A1

P356

P1433

P1476

Epidermal growth factor recept ...... t of hepatocellular carcinoma.

@en

P2093

Andrew Crenshaw

http://www.w3.org/2001/XMLSchema#string

Anthony D Schmitt

http://www.w3.org/2001/XMLSchema#string

Bradley Taylor

http://www.w3.org/2001/XMLSchema#string

Bryan C Fuchs

http://www.w3.org/2001/XMLSchema#string

Christopher M McGinn

http://www.w3.org/2001/XMLSchema#string

Danielle K DePeralta

http://www.w3.org/2001/XMLSchema#string

Gregory Y Lauwers

http://www.w3.org/2001/XMLSchema#string

Kenneth K Tanabe

http://www.w3.org/2001/XMLSchema#string

Lan Wei

http://www.w3.org/2001/XMLSchema#string

Michael Lanuti

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges

Genomic responses in mouse models poorly mimic human inflammatory diseases

Hepatocellular carcinoma

Hepatocellular carcinoma

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Mechanisms of hepatic fibrogenesis

TLR4 enhances TGF-beta signaling and hepatic fibrosis

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

Fibrosis-dependent mechanisms of hepatocarcinogenesis

P304

1577-1590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26898

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Nabeel Bardeesy

P577

2014-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261188302

http://www.w3.org/2001/XMLSchema#string

P698

24677197

http://www.w3.org/2001/XMLSchema#string

P932

4086837

http://www.w3.org/2001/XMLSchema#string